{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:36:53Z","timestamp":1782963413863,"version":"3.54.5"},"reference-count":267,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical observations and preclinical studies both suggest that Down syndrome (DS) may be associated with significant metabolic and bioenergetic alterations. However, the relevant scientific literature has not yet been systematically reviewed. The aim of the current study was to conduct a meta-analysis of metabolites involved in bioenergetics pathways in DS to conclusively determine the difference between DS and control subjects. We discuss these findings and their potential relevance in the context of pathogenesis and experimental therapy of DS. Articles published before July 1, 2020, were identified by using the search terms \u201cDown syndrome\u201d and \u201cmetabolite name\u201d or \u201ctrisomy 21\u201d and \u201cmetabolite name\u201d. Moreover, DS-related metabolomics studies and bioenergetics literature were also reviewed. 41 published reports and associated databases were identified, from which the descriptive information and the relevant metabolomic parameters were extracted and analyzed. Mixed effect model revealed the following changes in DS: significantly decreased ATP, CoQ10, homocysteine, serine, arginine and tyrosine; slightly decreased ADP; significantly increased uric acid, succinate, lactate and cysteine; slightly increased phosphate, pyruvate and citrate. However, the concentrations of AMP, 2,3-diphosphoglycerate, glucose, and glutamine were comparable in the DS vs. control populations. We conclude that cells of subjects with DS are in a pseudo-hypoxic state: the cellular metabolic and bio-energetic mechanisms exhibit pathophysiological alterations that resemble the cellular responses associated with hypoxia, even though the supply of the cells with oxygen is not disrupted. This fundamental alteration may be, at least in part, responsible for a variety of functional deficits associated with DS, including reduced exercise difference, impaired neurocognitive status and neurodegeneration.<\/jats:p>","DOI":"10.1186\/s10020-020-00225-8","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T23:02:36Z","timestamp":1604962956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome"],"prefix":"10.1186","volume":"26","author":[{"given":"Laszlo","family":"Pecze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa B.","family":"Randi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3110-4235","authenticated-orcid":false,"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"issue":"6","key":"225_CR1","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1542\/peds.2011-1262","volume":"129","author":"T Adelekan","year":"2012","unstructured":"Adelekan T, Magge S, Shults J, Stallings V, Stettler N. Lipid profiles of children with Down syndrome compared with their siblings. Pediatrics. 2012;129(6):e1382\u20137.","journal-title":"Pediatrics"},{"issue":"12","key":"225_CR2","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00702-008-0120-x","volume":"115","author":"AS Aguiar Jr","year":"2008","unstructured":"Aguiar AS Jr, Tuon T, Albuquerque MM, Rocha GS, Speck AE, Ara\u00fajo JC, et al. The exercise redox paradigm in the Down\u2019s syndrome: improvements in motor function and increases in blood oxidative status in young adults. J Neural Transm (Vienna). 2008;115(12):1643\u201350.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"225_CR3","doi-asserted-by":"publisher","first-page":"e0176307","DOI":"10.1371\/journal.pone.0176307","volume":"12","author":"S Aivazidis","year":"2017","unstructured":"Aivazidis S, Coughlan CM, Rauniyar AK, Jiang H, Liggett LA, Maclean KN, et al. The burden of trisomy 21 disrupts the proteostasis network in Down syndrome. PLoS ONE. 2017;12(4):e0176307.","journal-title":"PLoS ONE"},{"issue":"1","key":"225_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00283052","volume":"76","author":"KG Anner\u00e9n","year":"1987","unstructured":"Anner\u00e9n KG, Korenberg JR, Epstein CJ. Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21. Hum Genet. 1987;76(1):63\u20135.","journal-title":"Hum Genet"},{"issue":"4891","key":"225_CR5","first-page":"802","volume":"2","author":"XX Anon","year":"1954","unstructured":"Anon XX. Is mongolism a metabolic error? Br Med J. 1954;2(4891):802\u20133.","journal-title":"Br Med J."},{"issue":"1","key":"225_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis SE, Skotko BG, Rafii MS, Strydo A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers. 2020;6(1):9.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"225_CR7","doi-asserted-by":"publisher","first-page":"10491","DOI":"10.1038\/s41598-020-67195-z","volume":"10","author":"F Antonaros","year":"2020","unstructured":"Antonaros F, Ghini V, Pulina F, Ramacieri G, Cicchini E, Mannini E, et al. Plasma metabolome and cognitive skills in Down syndrome. Sci Rep. 2020;10(1):10491.","journal-title":"Sci Rep"},{"issue":"48","key":"225_CR8","doi-asserted-by":"publisher","first-page":"24231","DOI":"10.1073\/pnas.1908129116","volume":"116","author":"P Araya","year":"2019","unstructured":"Araya P, Waugh KA, Sullivan KD, N\u00fa\u00f1ez NG, Roselli E, Smith KP, et al. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci USA. 2019;116(48):24231\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"225_CR9","volume-title":"Biochemistry","author":"H Aziz","year":"2020","unstructured":"Aziz H, Mohiuddin SS. Biochemistry. Hexose Monophosphate Pathway: StatPearls Publishing, Treasure Island, FL; 2020."},{"issue":"7382","key":"225_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(65)90007-3","volume":"1","author":"A Baikie","year":"1965","unstructured":"Baikie A, Loder PB, De Gruchy G, Pitt D. Phosphohexokinase activity of erythrocytes in mongolism\u2014another possible marker for chromosome 21. Lancet. 1965;1(7382):412\u20134.","journal-title":"Lancet"},{"issue":"5","key":"225_CR11","doi-asserted-by":"publisher","first-page":"e0197711","DOI":"10.1371\/journal.pone.0197711","volume":"13","author":"U Bala","year":"2018","unstructured":"Bala U, Leong MP, Lim CL, Shahar HK, Othman F, Lai MI, et al. Defects in nerve conduction velocity and different muscle fibre-type specificity contribute to muscle weakness in Ts1Cje Down syndrome mouse model. PLoS ONE. 2018;13(5):e0197711.","journal-title":"PLoS ONE"},{"issue":"4","key":"225_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153\u201360.","journal-title":"Evid Based Ment Health"},{"issue":"5","key":"225_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/hmg\/ddaa003","volume":"29","author":"BP Bally","year":"2020","unstructured":"Bally BP, Farmer WT, Jones EV, Jessa S, Kacerovsky JB, Mayran A, et al. Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics. Hum Mol Genet. 2020;29(5):785\u2013802.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"225_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11940-008-0043-8","volume":"10","author":"KW Bara\u00f1ano","year":"2008","unstructured":"Bara\u00f1ano KW, Hartman AL. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr Treat Options Neurol. 2008;10(6):410\u20139.","journal-title":"Curr Treat Options Neurol"},{"issue":"4","key":"225_CR15","first-page":"344","volume":"9","author":"D Barca","year":"2014","unstructured":"Barca D, Tarta-Arsene O, Dica A, Iliescu C, Budisteanu M, Motoescu C, et al. Intellectual disability and epilepsy in Down syndrome. Maedica (Buchar). 2014;9(4):344\u201350.","journal-title":"Maedica (Buchar)"},{"issue":"4","key":"225_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/BF01633617","volume":"22","author":"H Bartels","year":"1971","unstructured":"Bartels H. Blood adenine nucleotides in Down\u2019s syndrome. Blut. 1971;22(4):216\u20137.","journal-title":"Blut"},{"issue":"3","key":"225_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0006-2944(74)90056-8","volume":"9","author":"SM Bayer","year":"1974","unstructured":"Bayer SM, McCoy EE. A comparison of the serotonin and ATP content in platelets from subjects with Down\u2019s syndrome. Biochem Med. 1974;9(3):225\u201332.","journal-title":"Biochem Med"},{"issue":"8","key":"225_CR18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/clinchem\/47.8.1500","volume":"47","author":"MC Belardinelli","year":"2001","unstructured":"Belardinelli MC, Chabli A, Chadefaux-Vekemans B, Kamoun P. Urinary sulfur compounds in Down syndrome. Clin Chem. 2001;47(8):1500\u20131.","journal-title":"Clin Chem"},{"issue":"8","key":"225_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.bbabio.2014.03.013","volume":"1837","author":"P B\u00e9nit","year":"2014","unstructured":"B\u00e9nit P, Letouz\u00e9 E, Rak M, Aubry L, Burnichon N, Favier J, et al. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling. Biochim Biophys Acta. 2014;1837(8):1330\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"225_CR20","volume-title":"Biochemistry","author":"JM Berg","year":"2008","unstructured":"Berg JM, Tymoczko JL, Stryer L. Biochemistry. Berlin: Springer; 2008."},{"key":"225_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ridd.2016.06.018","volume":"57","author":"F Bertapelli","year":"2016","unstructured":"Bertapelli F, Pitetti K, Agiovlasitis S, Guerra-Junior G. Overweight and obesity in children and adolescents with Down syndrome\u2014prevalence, determinants, consequences, and interventions: a literature review. Res Dev Disabil. 2016;57:181\u201392.","journal-title":"Res Dev Disabil"},{"issue":"6","key":"225_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000236899","volume":"31","author":"A Bhattacharyya","year":"2009","unstructured":"Bhattacharyya A, McMillan E, Chen SI, Wallace K, Svendsen CN. A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. Dev Neurosci. 2009;31(6):497\u2013510.","journal-title":"Dev Neurosci"},{"issue":"10","key":"225_CR23","first-page":"543","volume":"144","author":"JP Blass","year":"1988","unstructured":"Blass JP, Sheu RK, Cedarbaum JM. Energy metabolism in disorders of the nervous system. Rev Neurol (Paris). 1988;144(10):543\u201363.","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"225_CR24","doi-asserted-by":"publisher","first-page":"e8394","DOI":"10.1371\/journal.pone.0008394","volume":"5","author":"H Blehaut","year":"2010","unstructured":"Blehaut H, Mircher C, Ravel A, Conte M, De Portzamparc V, Poret G, et al. Effect of leucovorin (folinic acid) on the developmental quotient of children with Down\u2019s syndrome (trisomy 21) and influence of thyroid status. PLoS ONE. 2010;5(1):e8394.","journal-title":"PLoS ONE"},{"issue":"12","key":"225_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/jir.12687","volume":"63","author":"PH Boer","year":"2019","unstructured":"Boer PH, de Beer Z. The effect of aquatic exercises on the physical and functional fitness of adults with Down syndrome: a non-randomised controlled trial. J Intellect Disabil Res. 2019;63(12):1453\u201363.","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"225_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","volume":"8","author":"M Bonora","year":"2012","unstructured":"Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, et al. ATP synthesis and storage. Purinergic Signal. 2012;8(3):343\u201357.","journal-title":"Purinergic Signal"},{"key":"225_CR27","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2011","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis. Hoboken: Wiley; 2011."},{"issue":"3","key":"225_CR28","doi-asserted-by":"publisher","first-page":"e1005062","DOI":"10.1371\/journal.pgen.1005062","volume":"11","author":"V Brault","year":"2015","unstructured":"Brault V, Duchon A, Romestaing C, Sahun I, Pothion S, Karout M, et al. Opposite phenotypes of muscle strength and locomotor function in mouse models of partial trisomy and monosomy 21 for the proximal Hspa13-App region. PLoS Genet. 2015;11(3):e1005062.","journal-title":"PLoS Genet"},{"key":"225_CR29","first-page":"257","volume":"7","author":"WR Breg","year":"1977","unstructured":"Breg WR. Down syndrome: a review of recent progress in research. Pathobiol Annu. 1977;7:257\u2013303.","journal-title":"Pathobiol Annu"},{"issue":"1","key":"225_CR30","first-page":"110","volume":"90","author":"R Bronks","year":"1985","unstructured":"Bronks R, Parker AW. Anthropometric observation of adults with Down syndrome. Am J Ment Defic. 1985;90(1):110\u20133.","journal-title":"Am J Ment Defic"},{"issue":"24","key":"225_CR31","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1056\/NEJMra1706537","volume":"382","author":"MJ Bull","year":"2020","unstructured":"Bull MJ. Down syndrome. N Engl J Med. 2020;382(24):2344\u201352.","journal-title":"N Engl J Med"},{"issue":"2","key":"225_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/peds.2011-1605","volume":"128","author":"MJ Bull","year":"2011","unstructured":"Bull MJ. Committee on Genetics. Clinical report - Health supervision for children with Down syndrome. Pediatrics. 2011;128(2):393\u2013406.","journal-title":"Pediatrics"},{"issue":"5","key":"225_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","volume":"33","author":"J Busciglio","year":"2002","unstructured":"Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, et al. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down\u2019s syndrome. Neuron. 2002;33(5):677\u201388.","journal-title":"Neuron"},{"issue":"2","key":"225_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/tropej\/fmh089","volume":"51","author":"H \u00c7am","year":"2005","unstructured":"\u00c7am H, Yildirim B, Aydin A, Say A. Carnitine levels in neonatal hypoxia. J Trop Pediatr. 2005;51(2):106\u20138.","journal-title":"J Trop Pediatr"},{"issue":"3","key":"225_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.clinbiochem.2009.09.017","volume":"43","author":"C Campos","year":"2010","unstructured":"Campos C, Guzm\u00e1n R, L\u00f3pez-Fern\u00e1ndez E, Casado \u00c1. Urinary uric acid and antioxidant capacity in children and adults with Down syndrome. Clin Biochem. 2010;43(3):228\u201333.","journal-title":"Clin Biochem"},{"issue":"3","key":"225_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ajmg.c.30097","volume":"142C","author":"G Capone","year":"2006","unstructured":"Capone G, Goyal P, Ares W, Lannigan E. Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet. 2006;142C(3):158\u201372.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"225_CR37","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41598-018-20834-y","volume":"8","author":"M Caracausi","year":"2018","unstructured":"Caracausi M, Ghini V, Locatelli C, Mericio M, Piovesan A, Antonaros F, et al. Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism. Sci Rep. 2018;8(1):2977.","journal-title":"Sci Rep"},{"issue":"2","key":"225_CR38","doi-asserted-by":"publisher","first-page":"M106","DOI":"10.1093\/gerona\/57.2.M106","volume":"57","author":"E Carmeli","year":"2002","unstructured":"Carmeli E, Kessel S, Coleman R, Ayalon M. Effects of a treadmill walking program on muscle strength and balance in elderly people with Down syndrome. J Gerontol A Biol Sci Med Sci. 2002;57(2):M106\u201310.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7\u20138","key":"225_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbabio.2008.04.024","volume":"1777","author":"JE Carr\u00e9","year":"2008","unstructured":"Carr\u00e9 JE, Singer M. Cellular energetic metabolism in sepsis: the need for a systems approach. Biochim Biophys Acta. 2008;1777(7\u20138):763\u201371.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"225_CR40","first-page":"647","volume":"60","author":"A Chango","year":"2002","unstructured":"Chango A, Mircher C, James SJ, R\u00e9thor\u00e9 MO, Nicolas JP. One carbon metabolism and trisomy 21: analysis of the genetic polymorphism. Ann Biol Clin (Paris). 2002;60(6):647\u201353.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"Suppl","key":"225_CR41","first-page":"119","volume":"8","author":"M Chapman","year":"1964","unstructured":"Chapman M, Stern J. (1964) Uric acid in Downs disease. J Ment Defic Res. 1964;8(Suppl):119\u201324.","journal-title":"J Ment Defic Res"},{"issue":"9","key":"225_CR42","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1039\/c2mb25081k","volume":"8","author":"C-P Chen","year":"2012","unstructured":"Chen C-P, Chen Y-H, Chern S-R, Chang S-J, Tsai T-L, Li S-H, et al. Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery. Mol BioSyst. 2012;8(9):2360\u201372.","journal-title":"Mol BioSyst"},{"issue":"5","key":"225_CR43","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2018.03.002","volume":"27","author":"Q Chen","year":"2018","unstructured":"Chen Q, Kirk K, Shurubor YI, Zhao D, Arreguin AJ, Shahi I, et al. Rewiring of glutamine metabolism is a bioenergetic adaptation of human cells with mitochondrial DNA mutations. Cell Metab. 2018;27(5):1007-1025.e5.","journal-title":"Cell Metab"},{"issue":"1","key":"225_CR44","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1038\/s41467-018-07630-y","volume":"9","author":"JC Chiang","year":"2018","unstructured":"Chiang JC, Jiang J, Newburger PE, Lawrence JB. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro. Nat Commun. 2018;9(1):5180.","journal-title":"Nat Commun"},{"issue":"7527","key":"225_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, Aksentijevi\u0107 D, Sundier SY, Robb EL, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431\u20135.","journal-title":"Nature"},{"issue":"2","key":"225_CR46","first-page":"166","volume":"99","author":"M Cioni","year":"1994","unstructured":"Cioni M, Cocilovo A, Di Pasquale F, Araujo MB, Siqueira CR, Bianco M. Strength deficit of knee extensor muscles of individuals with Down syndrome from childhood to adolescence. Am J Ment Retard. 1994;99(2):166\u201374.","journal-title":"Am J Ment Retard"},{"issue":"4","key":"225_CR47","first-page":"287","volume":"3","author":"B Cisterna","year":"2014","unstructured":"Cisterna B, Costanzo M, Scherini E, Zancanaro C, Malatesta M. Ultrastructural features of skeletal muscle in adult and aging Ts65Dn mice, a murine model of Down syndrome. Muscles Ligaments Tendons J. 2014;3(4):287\u201394.","journal-title":"Muscles Ligaments Tendons J"},{"key":"225_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exger.2019.01.028","volume":"119","author":"HJ Coelho-Junior","year":"2019","unstructured":"Coelho-Junior HJ, Villani ER, Calvani R, Carf\u00ec A, Picca A, Landi F, et al. Sarcopenia-related parameters in adults with Down syndrome: a cross-sectional exploratory study. Exp Gerontol. 2019;119:93\u20139.","journal-title":"Exp Gerontol"},{"issue":"1","key":"225_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.01.003","volume":"91","author":"A Contestabile","year":"2010","unstructured":"Contestabile A, Benfenati F, Gasparini L. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol. 2010;91(1):1\u201322.","journal-title":"Prog Neurobiol"},{"issue":"8","key":"225_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hipo.20308","volume":"17","author":"A Contestabile","year":"2007","unstructured":"Contestabile A, Fila T, Ceccarelli C, Bonasoni P, Bonapace L, Santini D, et al. Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus. 2007;17(8):665\u201378.","journal-title":"Hippocampus"},{"key":"225_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1471-2164-8-268","volume":"8","author":"A Conti","year":"2007","unstructured":"Conti A, Fabbrini F, D\u2019Agostino P, Negri R, Greco D, Genesio R, et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics. 2007;8:268.","journal-title":"BMC Genomics"},{"issue":"4","key":"225_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/imm.12659","volume":"149","author":"P Convertini","year":"2016","unstructured":"Convertini P, Menga A, Andria G, Scala I, Santarsiero A, Castiglione Morelli MA, et al. The contribution of the citrate pathway to oxidative stress in Down syndrome. Immunology. 2016;149(4):423\u201331.","journal-title":"Immunology"},{"issue":"2","key":"225_CR53","first-page":"185","volume":"9","author":"MM Conway","year":"1970","unstructured":"Conway MM, Layzer RB. Blood cell phosphofructokinase in Down\u2019s syndrome. Humangenetik. 1970;9(2):185\u201390.","journal-title":"Humangenetik"},{"issue":"1","key":"225_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mrrev.2009.06.001","volume":"682","author":"F Copped\u00e8","year":"2009","unstructured":"Copped\u00e8 F. The complex relationship between folate\/homocysteine metabolism and risk of Down syndrome. Mutat Res. 2009;682(1):54\u201370.","journal-title":"Mutat Res"},{"issue":"8","key":"225_CR55","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00702-007-0656-1","volume":"114","author":"AW Coppus","year":"2007","unstructured":"Coppus AW, Fekkes D, Verhoeven WM, Tuinier S, Egger JI, van Duijn CM. Plasma amino acids and neopterin in healthy persons with Down\u2019s syndrome. J Neural Transm (Vienna). 2007;114(8):1041\u20135.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"225_CR56","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MCO.0000000000000178","volume":"18","author":"C Corbet","year":"2015","unstructured":"Corbet C, Feron O. (2015) Metabolic and mind shifts: from glucose to glutamine and acetate addictions in cancer. Curr Opin Clin Nutr Metab Care. 2015;18(4):346\u201353.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"225_CR57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.archger.2007.10.011","volume":"48","author":"MM Corsi","year":"2009","unstructured":"Corsi MM, Dogliotti G, Pedroni F, Galliera E, Malavazos AE, Villa R, et al. Adipocytokines in Down\u2019s syndrome, an atheroma-free model: Role of adiponectin. Arch Gerontol Geriatr. 2009;48(1):106\u20139.","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"225_CR58","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3233\/JAD-160278","volume":"55","author":"P Coskun","year":"2017","unstructured":"Coskun P, Helguera P, Nemati Z, Bohannan RC, Thomas J, Samuel SE, et al. Metabolic and growth rate alterations in lymphoblastic cell lines discriminate between Down syndrome and Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55(2):737\u201348.","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"225_CR59","doi-asserted-by":"publisher","first-page":"R1251","DOI":"10.1152\/ajpregu.00312.2012","volume":"303","author":"PM Cowley","year":"2012","unstructured":"Cowley PM, Keslacy S, Middleton FA, DeRuisseau LR, Fernhall B, Kanaley JA, et al. Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition. Am J Physiol Regul Integr Comp Physiol. 2012;303(12):R1251\u201360.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"225_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.redox.2017.07.003","volume":"13","author":"PM Cowley","year":"2017","unstructured":"Cowley PM, Nair DR, DeRuisseau LR, Keslacy S, Atalay M, DeRuisseau KC. Oxidant production and SOD1 protein expression in single skeletal myofibers from Down syndrome mice. Redox Biol. 2017;13:421\u20135.","journal-title":"Redox Biol"},{"issue":"4","key":"225_CR61","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0003-9993(96)90086-6","volume":"77","author":"RV Croce","year":"1996","unstructured":"Croce RV, Pitetti KH, Horvat M, Miller J. Peak torque, average power, and hamstrings\/quadriceps ratios in nondisabled adults and adults with mental retardation. Arch Phys Med Rehabil. 1996;77(4):369\u201372.","journal-title":"Arch Phys Med Rehabil"},{"issue":"27","key":"225_CR62","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1182\/bloodadvances.2017011957","volume":"1","author":"R Culp-Hill","year":"2017","unstructured":"Culp-Hill R, Zheng C, Reisz JA, Smith K, Rachubinski A, Nemkov T, et al. Red blood cell metabolism in Down syndrome: hints on metabolic derangements in aging. Blood Adv. 2017;1(27):2776\u201380.","journal-title":"Blood Adv"},{"issue":"15","key":"225_CR63","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.clinbiochem.2013.04.027","volume":"46","author":"M Dashty","year":"2013","unstructured":"Dashty M. (2013) A quick look at biochemistry: carbohydrate metabolism. Clin Biochem. 2013;46(15):1339\u201352.","journal-title":"Clin Biochem"},{"issue":"11","key":"225_CR64","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1016\/j.ridd.2014.07.038","volume":"35","author":"DR de Asua","year":"2014","unstructured":"de Asua DR, Parra P, Costa R, Moldenhauer F, Suarez C. Evaluation of the impact of abdominal obesity on glucose and lipid metabolism disorders in adults with Down syndrome. Res Dev Disabil. 2014a;35(11):2942\u20139.","journal-title":"Res Dev Disabil"},{"issue":"6","key":"225_CR65","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4093\/dmj.2014.38.6.464","volume":"38","author":"DR de Asua","year":"2014","unstructured":"de Asua DR, Parra P, Costa R, Moldenhauer F, Suarez C. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome. Diabetes Metab J. 2014b;38(6):464\u201371.","journal-title":"Diabetes Metab J"},{"issue":"8","key":"225_CR66","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","volume":"15","author":"R de la Torre","year":"2016","unstructured":"de la Torre R, de Sola S, Hernandez G, Farr\u00e9 M, Pujol J, Rodriguez J, et al. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15(8):801\u201310.","journal-title":"Lancet Neurol"},{"issue":"2","key":"225_CR67","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mnfr.201300325","volume":"58","author":"R de la Torre","year":"2014","unstructured":"de la Torre R, de Sola S, Pons M, Duchon A, de Lagran MM, Farr\u00e9 M, et al. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res. 2014;58(2):278\u201388.","journal-title":"Mol Nutr Food Res"},{"key":"225_CR68","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jpeds.2017.07.011","volume":"189","author":"A De Matteo","year":"2017","unstructured":"De Matteo A, Vajro P. Down syndrome and pediatric nonalcoholic fatty liver disease: a causal or casual relationship? J Pediatr. 2017;189:11\u20133.","journal-title":"J Pediatr"},{"issue":"4","key":"225_CR69","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.archoralbio.2014.09.013","volume":"60","author":"MC de Sousa","year":"2015","unstructured":"de Sousa MC, Vieira RB, dos Santos DS, Carvalho CAT, Camargo SEA, Mancini MNG, et al. Antioxidants and biomarkers of oxidative damage in the saliva of patients with Down\u2019s syndrome. Arch Oral Biol. 2015;60(4):600\u20135.","journal-title":"Arch Oral Biol"},{"issue":"11","key":"225_CR70","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbabio.2009.01.005","volume":"1787","author":"RM Denton","year":"2009","unstructured":"Denton RM. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim Biophys Acta. 2009;1787(11):1309\u201316.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"225_CR71","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.apmr.2005.06.003","volume":"86","author":"KJ Dodd","year":"2005","unstructured":"Dodd KJ, Shields N. A systematic review of the outcomes of cardiovascular exercise programs for people with Down syndrome. Arch Phys Med Rehab. 2005;86(10):2051\u20138.","journal-title":"Arch Phys Med Rehab"},{"issue":"1","key":"225_CR72","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1096\/fj.15-276337","volume":"30","author":"JC Drake","year":"2016","unstructured":"Drake JC, Wilson RJ, Yan Z. Molecular mechanisms for mitochondrial adaptation to exercise training in skeletal muscle. FASEB J. 2016;30(1):13\u201322.","journal-title":"FASEB J"},{"issue":"2","key":"225_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0921-8777(98)00042-1","volume":"409","author":"N Druzhyna","year":"1998","unstructured":"Druzhyna N, Nair RG, LeDoux SP, Wilson GL. Defective repair of oxidative damage in mitochondrial DNA in Down\u2019s syndrome. Mutat Res. 1998;409(2):81\u20139.","journal-title":"Mutat Res"},{"key":"225_CR74","volume-title":"Physiology, Adenosine Triphosphate (ATP)","author":"J Dunn","year":"2020","unstructured":"Dunn J, Grider MH. Physiology, Adenosine Triphosphate (ATP). Treasure Island: StatPearls Publishing; 2020."},{"issue":"12","key":"225_CR75","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/01.JAA.0000526779.77230.79","volume":"30","author":"C Dupre","year":"2017","unstructured":"Dupre C, Weidman-Evans E. Musculoskeletal development in patients with Down syndrome. JAAPA. 2017;30(12):38\u201340.","journal-title":"JAAPA"},{"issue":"1","key":"225_CR76","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1038\/oncsis.2015.50","volume":"5","author":"K Eales","year":"2016","unstructured":"Eales K, Hollinshead K, Tennant D. Hypoxia and metabolic adaptation of cancer cells. Oncogenesis. 2016;5(1):e190.","journal-title":"Oncogenesis"},{"issue":"2","key":"225_CR77","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/01652176.1980.9693766","volume":"2","author":"JO Egekeze","year":"1980","unstructured":"Egekeze JO, Oehme FW. Cyanides and their toxicity: a literature review. Vet Q. 1980;2(2):104\u201314.","journal-title":"Vet Q"},{"issue":"7644","key":"225_CR78","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/bmj.39465.544028.AE","volume":"336","author":"JM Ellis","year":"2008","unstructured":"Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R, et al. Supplementation with antioxidants and folinic acid for children with Down\u2019s syndrome: randomised controlled trial. BMJ. 2008;336(7644):594\u20137.","journal-title":"BMJ"},{"issue":"3","key":"225_CR79","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/oby.2011.93","volume":"20","author":"AK Elshorbagy","year":"2012","unstructured":"Elshorbagy AK, Smith AD, Kozichm V, Refsum H. Cysteine and obesity. Obesity (Silver Spring). 2012;20(3):473\u201381.","journal-title":"Obesity (Silver Spring)"},{"issue":"10","key":"225_CR80","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2174\/1389450111007011193","volume":"11","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multiple defects in energy metabolism in Alzheimer\u2019s disease. Curr Drug Targets. 2010;11(10):1193\u2013206.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"225_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1289\/ehp.10531","volume":"116","author":"N Fiedler","year":"2008","unstructured":"Fiedler N, Kipen H, Ohman-Strickland P, Zhang J, Weisel C, Laumbach R, et al. Sensory and cognitive effects of acute exposure to hydrogen sulfide. Environ Health Perspect. 2008;116(1):78\u201385.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"225_CR82","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/j.1471-4159.1981.tb00417.x","volume":"36","author":"J Folbergrov\u00e0","year":"1981","unstructured":"Folbergrov\u00e0 J, Nilsson B, Sakabe T, Siesj\u00f6 BK. The influence of hypoxia on the concentrations of cyclic nucleotides in the rat brain. J Neurochem. 1981;36(5):1670\u20134.","journal-title":"J Neurochem"},{"key":"225_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6823-5-6","volume":"5","author":"CT Fonseca","year":"2005","unstructured":"Fonseca CT, Amaral DM, Ribeiro MG, Beserra IC, Guimar\u00e3es MM. Insulin resistance in adolescents with Down syndrome: a cross-sectional study. BMC Endocr Disord. 2005;5:6.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"225_CR84","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0272-0590(86)90147-8","volume":"7","author":"RA Frakes","year":"1986","unstructured":"Frakes RA, Sharma RP, Willhite CC, Gomez G. Effect of cyanogenic glycosides and protein content in cassava diets on hamster prenatal development. Fundam Appl Toxicol. 1986;7(2):191\u20138.","journal-title":"Fundam Appl Toxicol"},{"issue":"3533","key":"225_CR85","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.137.3533.868","volume":"137","author":"RW Fuller","year":"1962","unstructured":"Fuller RW, Luce MW, Mertz ET. Serum uric acid in mongolism. Science. 1962;137(3533):868\u20139.","journal-title":"Science"},{"issue":"9","key":"225_CR86","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/infdis\/jiu273","volume":"210","author":"HA Funes","year":"2014","unstructured":"Funes HA, Apostolova N, Alegre F, Blas-Garcia A, Alvarez A, Marti-Cabrera M, et al. Neuronal bioenergetics and acute mitochondrial dysfunction: a clue to understanding the central nervous system side effects of efavirenz. J Infect Dis. 2014;210(9):1385\u201395.","journal-title":"J Infect Dis"},{"issue":"18","key":"225_CR87","doi-asserted-by":"crossref","first-page":"13623","DOI":"10.1016\/S0021-9258(17)36875-8","volume":"269","author":"D Gabuzda","year":"1994","unstructured":"Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem. 1994;269(18):13623\u20138.","journal-title":"J Biol Chem"},{"key":"225_CR88","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/DDDT.S51476","volume":"9","author":"KJ Gardiner","year":"2014","unstructured":"Gardiner KJ. Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. Drug Des Devel Ther. 2014;9:103\u201325.","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"225_CR89","doi-asserted-by":"publisher","first-page":"e0158008","DOI":"10.1371\/journal.pone.0158008","volume":"11","author":"TJ Glass","year":"2016","unstructured":"Glass TJ, Connor NP. Digastric muscle phenotypes of the Ts65Dn mouse model of Down syndrome. PLoS ONE. 2016;11(6):e0158008.","journal-title":"PLoS ONE"},{"issue":"7","key":"225_CR90","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","volume":"155","author":"AP Gomes","year":"2013","unstructured":"Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624\u201338.","journal-title":"Cell"},{"issue":"5","key":"225_CR91","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.ridd.2011.02.023","volume":"32","author":"A Gonz\u00e1lez-Ag\u00fcero","year":"2011","unstructured":"Gonz\u00e1lez-Ag\u00fcero A, Ara I, Moreno LA, Vicente-Rodr\u00edguez G, Casaj\u00fas JA. Fat and lean masses in youths with Down syndrome: gender differences. Res Dev Disabil. 2011;32(5):1685\u201393.","journal-title":"Res Dev Disabil"},{"issue":"2","key":"225_CR92","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/ajmg.c.31439","volume":"169","author":"J Grieco","year":"2015","unstructured":"Grieco J, Pulsifer M, Seligsohn K, Skotko B, Schwartz A. Down syndrome: cognitive and behavioral functioning across the lifespan. Am J Med Genet C Semin Med Genet. 2015;169(2):135\u201349.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"225_CR93","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/dneu.22716","volume":"79","author":"TJ Gross","year":"2019","unstructured":"Gross TJ, Doran E, Cheema AK, Head E, Lott IT, Mapstone M. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer\u2019s disease. Dev Neurobiol. 2019;79(7):622\u201338.","journal-title":"Dev Neurobiol"},{"issue":"17","key":"225_CR94","doi-asserted-by":"publisher","first-page":"13223","DOI":"10.1074\/jbc.M110.102574","volume":"285","author":"X Guo","year":"2010","unstructured":"Guo X, Williams JG, Schug TT, Li X. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J Biol Chem. 2010;285(17):13223\u201332.","journal-title":"J Biol Chem"},{"issue":"11\u201312","key":"225_CR95","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00335-016-9661-8","volume":"27","author":"M Gupta","year":"2016","unstructured":"Gupta M, Dhanasekaran AR, Gardiner KJ. Mouse models of Down syndrome: gene content and consequences. Mamm Genome. 2016;27(11\u201312):538\u201355.","journal-title":"Mamm Genome"},{"key":"225_CR96","volume-title":"Biochemistry Citric Acid Cycle","author":"A Haddad","year":"2019","unstructured":"Haddad A, Mohiuddin SS. Biochemistry Citric Acid Cycle. Treasure Island: StatPearls Publishing; 2019."},{"issue":"2","key":"225_CR97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0304-3940(91)90864-P","volume":"122","author":"RS Hannah","year":"1991","unstructured":"Hannah RS, Roth SH. Chronic exposure to low concentrations of hydrogen sulfide produces abnormal growth in developing cerebellar Purkinje cells. Neurosci Lett. 1991;122(2):225\u20138.","journal-title":"Neurosci Lett"},{"issue":"6","key":"225_CR98","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrendo.2009.80","volume":"5","author":"Y Hawli","year":"2009","unstructured":"Hawli Y, Nasrallah M, El-Hajj FG. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol. 2009;5(6):327\u201334.","journal-title":"Nat Rev Endocrinol"},{"issue":"7630","key":"225_CR99","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nature20127","volume":"539","author":"E Hebert-Chatelain","year":"2016","unstructured":"Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, et al. A cannabinoid link between mitochondria and memory. Nature. 2016;539(7630):555\u20139.","journal-title":"Nature"},{"issue":"2","key":"225_CR100","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV. Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Stat Educ. 1981;6(2):107\u201328.","journal-title":"J Stat Educ"},{"issue":"4","key":"225_CR101","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/adc.74.4.347","volume":"74","author":"H Heggarty","year":"1996","unstructured":"Heggarty H, Ball R, Smith M, Henderson M. Amino acid profile in Down\u2019s syndrome. Arch Dis Child. 1996;74(4):347\u20139.","journal-title":"Arch Dis Child"},{"issue":"1","key":"225_CR102","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cmet.2012.12.005","volume":"17","author":"P Helguera","year":"2013","unstructured":"Helguera P, Seiglie J, Rodriguez J, Hanna M, Helguera G, Busciglio J. Adaptive downregulation of mitochondrial function in down syndrome. Cell Metab. 2013;17(1):132\u201340.","journal-title":"Cell Metab"},{"issue":"10","key":"225_CR103","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1242\/dmm.029728","volume":"10","author":"Y Herault","year":"2017","unstructured":"Herault Y, Delabar JM, Fisher EMC, Tybulewicz VLJ, Yu E, Brault V. Rodent models in Down syndrome research: impact and future opportunities. Dis Model Mech. 2017;10(10):1165\u201386.","journal-title":"Dis Model Mech"},{"key":"225_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/9780470712184","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2008","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley; 2008."},{"issue":"10","key":"225_CR105","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ejcn.2013.137","volume":"67","author":"DL Hill","year":"2013","unstructured":"Hill DL, Parks EP, Zemel BS, Shults J, Stallings VA, Stettler N. Resting energy expenditure and adiposity accretion among children with Down syndrome: a 3-year prospective study. Eur J Clin Nutr. 2013;67(10):1087\u201391.","journal-title":"Eur J Clin Nutr"},{"issue":"15","key":"225_CR106","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1042\/BCJ20160009","volume":"473","author":"DA Hood","year":"2016","unstructured":"Hood DA, Tryon LD, Carter HN, Kim Y, Chen CC. Unravelling the mechanisms regulating muscle mitochondrial biogenesis. Biochem J. 2016;473(15):2295\u2013314.","journal-title":"Biochem J"},{"issue":"2","key":"225_CR107","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0609.1973.tb00108.x","volume":"11","author":"A Howell","year":"1973","unstructured":"Howell A, Mason A, Brown E, Watts R, Chanarin I, McPherson K, et al. Red cell size and uric acid in Down\u2019s syndrome. Scand J Haematol. 1973;11(2):140\u20137.","journal-title":"Scand J Haematol"},{"issue":"3","key":"225_CR108","first-page":"245","volume":"2","author":"S Hoyer","year":"1990","unstructured":"Hoyer S. Brain glucose and energy metabolism during normal aging. Aging (Milano). 1990;2(3):245\u201358.","journal-title":"Aging (Milano)"},{"key":"225_CR109","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1749-6632.1993.tb23032.x","volume":"695","author":"S Hoyer","year":"1993","unstructured":"Hoyer S. Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. Ann NY Acad Sci. 1993;695:77\u201380.","journal-title":"Ann NY Acad Sci"},{"issue":"S1","key":"225_CR110","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","volume":"18","author":"W Huber","year":"2002","unstructured":"Huber W, Von Heydebreck A, S\u00fcltmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(S1):S96-104.","journal-title":"Bioinformatics"},{"issue":"4","key":"225_CR111","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.stemcr.2018.02.001","volume":"10","author":"HQ Huo","year":"2018","unstructured":"Huo HQ, Qu ZY, Yuan F, Ma L, Yao L, Xu M, et al. Modeling Down syndrome with patient iPSCs reveals cellular and migration deficits of GABAergic neurons. Stem Cell Reports. 2018;10(4):1251\u201366.","journal-title":"Stem Cell Reports"},{"key":"225_CR112","unstructured":"Igoe A, Roller BA, Elangovan A, Kaelber KL, Kaelber D. A case series of gout and Downs Syndrome\u2014a new paradigm for detecting disease associations using big data. In: Arthritis and Rheumatology, Vol 69. Hoboken: Wiley. 2017."},{"issue":"3","key":"225_CR113","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ymgme.2010.11.166","volume":"102","author":"V Infantino","year":"2011","unstructured":"Infantino V, Castegna A, Iacobazzi F, Spera I, Scala I, Andria G, et al. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down\u2019s syndrome. Mol Genet Metab. 2011;102(3):378\u201382.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"225_CR114","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3390\/brainsci7040044","volume":"7","author":"K Ishihara","year":"2017","unstructured":"Ishihara K, Akiba S. A comprehensive diverse \u2018-omics\u2019 approach to better understanding the molecular pathomechanisms of down syndrome. Brain Sci. 2017;7(4):44.","journal-title":"Brain Sci"},{"issue":"1","key":"225_CR115","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s10020-018-0004-y","volume":"24","author":"A Izzo","year":"2018","unstructured":"Izzo A, Mollo N, Nitti M, Paladino S, Cal\u00ec G, Genesio R, et al. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets. Mol Med. 2018;24(1):2.","journal-title":"Mol Med"},{"issue":"6","key":"225_CR116","first-page":"1056","volume":"26","author":"A Izzo","year":"2017","unstructured":"Izzo A, Nitti M, Mollo N, Paladino S, Procaccini C, Faicchia D, et al. Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells. Hum Mol Genet. 2017;26(6):1056\u201369.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"225_CR117","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.crvi.2006.06.004","volume":"329","author":"B Jablonska","year":"2006","unstructured":"Jablonska B, Ford D, Trisler D, Pessac B. The growth capacity of bone marrow CD34 positive cells in culture is drastically reduced in a murine model of Down syndrome. C R Biol. 2006;329(9):726\u201332.","journal-title":"C R Biol"},{"issue":"9177","key":"225_CR118","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(98)91132-1","volume":"354","author":"JH James","year":"1999","unstructured":"James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 1999;354(9177):505\u20138.","journal-title":"Lancet"},{"issue":"7462","key":"225_CR119","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/nature12394","volume":"500","author":"J Jiang","year":"2013","unstructured":"Jiang J, Jing Y, Cost GJ, Chiang J-C, Kolpa HJ, Cotton AM, et al. Translating dosage compensation to trisomy 21. Nature. 2013;500(7462):296\u2013300.","journal-title":"Nature"},{"issue":"6","key":"225_CR120","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cancers11060804","volume":"11","author":"J Jiang","year":"2019","unstructured":"Jiang J, Srivastava S, Zhang J. Starve cancer cells of glutamine: Break the spell or make a hungry monster? Cancers (Basel). 2019;11(6):804.","journal-title":"Cancers (Basel)"},{"key":"225_CR121","doi-asserted-by":"crossref","unstructured":"Kamoun PP. Mental retardation in Down syndrome: two ways to treat. Med Hypotheses. 2019;131:109289.","DOI":"10.1016\/j.mehy.2019.109289"},{"issue":"3","key":"225_CR122","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajmg.a.10847","volume":"116A","author":"P Kamoun","year":"2003","unstructured":"Kamoun P, Belardinelli MC, Chabli A, Lallouchi K, Chadefaux-Vekemans B. Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet A. 2003;116A(3):310\u20131.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"225_CR123","doi-asserted-by":"publisher","first-page":"11","DOI":"10.29245\/2578-2940\/2018\/2.1121","volume":"2","author":"KN Kaneko","year":"2018","unstructured":"Kaneko KN, Wong M, Corley MJ, Lee RWY. The ketogenic diet as a potential therapy in Down syndrome. J Pediatr Pediatr Med. 2018;2(2):11\u20137.","journal-title":"J Pediatr Pediatr Med"},{"issue":"17","key":"225_CR124","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1056\/NEJM196704272761704","volume":"276","author":"JM Kaufman","year":"1967","unstructured":"Kaufman JM, O\u2019Brien WM. Hyperuricemia in mongolism. N Engl J Med. 1967;276(17):953\u20136.","journal-title":"N Engl J Med"},{"key":"225_CR125","doi-asserted-by":"publisher","first-page":"e56223","DOI":"10.7554\/eLife.56223","volume":"9","author":"Y Kazuki","year":"2020","unstructured":"Kazuki Y, Gao FJ, Li Y, Moyer AJ, Devenney B, Hiramatsu K, et al. A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21. Elife. 2020;9:e56223.","journal-title":"Elife"},{"issue":"1","key":"225_CR126","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1203\/00006450-197201000-00002","volume":"6","author":"J Kedziora","year":"1972","unstructured":"Kedziora J, H\u00fcbner H, Kanski M, Jeske J, Leyko W. Efficiency of the glycolytic pathway in erythrocytes of children with Down\u2019s syndrome. Pediatr Res. 1972;6(1):10\u20137.","journal-title":"Pediatr Res"},{"issue":"8","key":"225_CR127","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1242\/dmm.025668","volume":"9","author":"H Kim","year":"2016","unstructured":"Kim H, Lee K-S, Kim A-K, Choi M, Choi K, Kang M, et al. A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition. Dis Models Mech. 2016;9(8):839\u201348.","journal-title":"Dis Models Mech"},{"issue":"24","key":"225_CR128","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1016\/S0024-3205(01)01074-8","volume":"68","author":"SH Kim","year":"2001","unstructured":"Kim SH, Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G. The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer\u2019s disease. Life Sci. 2001;68(24):2741\u201350.","journal-title":"Life Sci"},{"issue":"1","key":"225_CR129","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","volume":"16","author":"R Kimura","year":"2007","unstructured":"Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, et al. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet. 2007;16(1):15\u201323.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"225_CR130","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/BF01922912","volume":"34","author":"HR Knull","year":"1978","unstructured":"Knull HR, Bronstein WW, Porter PJ. Adenosine triphosphate and diphosphoglycerate levels in red blood cells from patients with Down\u2019s syndrome. Experientia. 1978;34(9):1133\u20134.","journal-title":"Experientia"},{"issue":"6","key":"225_CR131","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/apa.15153","volume":"109","author":"N Lagan","year":"2020","unstructured":"Lagan N, Huggard D, Mc Grane F, Leahy TR, Franklin O, Roche E, et al. Multiorgan involvement and management in children with Down syndrome. Acta Paediatr. 2020;109(6):1096\u2013111.","journal-title":"Acta Paediatr"},{"key":"225_CR132","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2018.03.001","volume":"67","author":"EL Larsen","year":"2018","unstructured":"Larsen EL, Padella L, Bergholdt HKM, Henriksen T, Santoro L, Gabrielli O, et al. The effect of long-term treatment with coenzyme Q10 on nucleic acid modifications by oxidation in children with Down syndrome. Neurobiol Aging. 2018;67:159\u201361.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"225_CR133","first-page":"533","volume":"24","author":"RB Layzer","year":"1972","unstructured":"Layzer RB, Epstein CJ. Phosphofructokinase and chromosome 21. Am J Hum Genet. 1972;24(5):533\u201343.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"225_CR134","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"225_CR135","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.molmed.2019.10.001","volume":"26","author":"SE Lee","year":"2020","unstructured":"Lee SE, Duran-Martinez M, Khantsis S, Bianchi DW, Guedj F. Challenges and opportunities for translation of therapies to improve cognition in Down syndrome. Trends Mol Med. 2020;26(2):150\u201369.","journal-title":"Trends Mol Med"},{"issue":"2","key":"225_CR136","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1016-8478(23)13725-3","volume":"15","author":"SH Lee","year":"2003","unstructured":"Lee SH, Lee S, Jun HS, Jeong HJ, Cha WT, Cho YS, et al. Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome. Mol Cells. 2003;15(2):181\u20135.","journal-title":"Mol Cells"},{"key":"225_CR137","first-page":"20","volume":"7","author":"J Lejeune","year":"1990","unstructured":"Lejeune J. Pathogenesis of mental deficiency in trisomy 21. Am J Med Genet Suppl. 1990;7:20\u201330.","journal-title":"Am J Med Genet Suppl"},{"issue":"1","key":"225_CR138","first-page":"8","volume":"35","author":"J Lejeune","year":"1992","unstructured":"Lejeune J, Rethor\u00e9 MO, de Blois MC, Peeters M, Naffah J, Megarbane A, et al. Amino acids and trisomy 21. Ann Genet. 1992;35(1):8\u201313.","journal-title":"Ann Genet"},{"issue":"7496","key":"225_CR139","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature13200","volume":"508","author":"A Letourneau","year":"2014","unstructured":"Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, et al. Domains of genome-wide gene expression dysregulation in Down\u2019s syndrome. Nature. 2014;508(7496):345\u201350.","journal-title":"Nature"},{"issue":"W1","key":"225_CR140","doi-asserted-by":"publisher","first-page":"W162","DOI":"10.1093\/nar\/gkx449","volume":"45","author":"B Li","year":"2017","unstructured":"Li B, Tang J, Yang Q, Li S, Cui X, Li Y, et al. NOREVA: normalization and evaluation of MS-based metabolomics data. Nucleic Acids Res. 2017;45(W1):W162\u201370.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"225_CR141","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41467-017-01422-6","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Borel C, Li L, M\u00fcller T, Williams EG, Germain P-L, et al. Systematic proteome and proteostasis profiling in human Trisomy 21 fibroblast cells. Nat Commun. 2017;8(1):1212.","journal-title":"Nat Commun"},{"issue":"15","key":"225_CR142","doi-asserted-by":"publisher","first-page":"e15221","DOI":"10.1097\/MD.0000000000015221","volume":"98","author":"O L\u00f3pez-Su\u00e1rez","year":"2019","unstructured":"L\u00f3pez-Su\u00e1rez O, Concheiro-Guis\u00e1n A, S\u00e1nchez-Pintos P, Cocho JA, Lorenzo JRF, Couce ML. Acylcarnitine profile in neonatal hypoxic-ischemic encephalopathy: the value of butyrylcarnitine as a prognostic marker. Medicine (Baltimore). 2019;98(15):e15221.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"225_CR143","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/ajmg.a.34114","volume":"155A","author":"IT Lott","year":"2011","unstructured":"Lott IT, Doran E, Nguyen VQ, Tournay A, Head E, Gillen DL. Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. Am J Med Genet A. 2011;155A(8):1939\u201348.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"225_CR144","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2174\/156720506779025305","volume":"3","author":"IT Lott","year":"2006","unstructured":"Lott IT, Head E, Doran E, Busciglio J. Beta-amyloid, oxidative stress and Down syndrome. Curr Alzheimer Res. 2006;3(5):521\u20138.","journal-title":"Curr Alzheimer Res"},{"key":"225_CR145","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.acdb.2019.01.002","volume":"56","author":"AF Lukowski","year":"2019","unstructured":"Lukowski AF, Milojevich HM, Eales L. Cognitive functioning in children with Down syndrome: current knowledge and future directions. Adv Child Dev Behav. 2019;56:257\u201389.","journal-title":"Adv Child Dev Behav"},{"key":"225_CR146","first-page":"001056","volume":"1","author":"J Lumley","year":"2001","unstructured":"Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and\/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev. 2001;1:001056.","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"225_CR147","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2044.1977.tb10002.x","volume":"32","author":"R MacDonald","year":"1977","unstructured":"MacDonald R. Red cell 2,3-diphosphoglycerate and oxygen affinity. Anaesthesia. 1977;32(6):544\u201353.","journal-title":"Anaesthesia"},{"issue":"3","key":"225_CR148","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpeds.2007.08.008","volume":"152","author":"SN Magge","year":"2008","unstructured":"Magge SN, O\u2019Neill KL, Shults J, Stallings VA, Stettler N. Leptin levels among prepubertal children with Down syndrome compared with their siblings. J Pediatr. 2008;152(3):321\u20136.","journal-title":"J Pediatr"},{"issue":"11","key":"225_CR149","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/sj.ejcn.1602000","volume":"58","author":"P Magni","year":"2004","unstructured":"Magni P, Ruscica M, Dozio E, Roti E, Licastro F, Motta M, et al. Free and bound leptin in prepubertal children with Down\u2019s syndrome and different degrees of adiposity. Eur J Clin Nutr. 2004;58(11):1547\u20139.","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl","key":"225_CR150","first-page":"123","volume":"22","author":"AC Malegiannaki","year":"2019","unstructured":"Malegiannaki AC, Katsarou D, Liolios A, Zisi V. Ageing and Down syndrome: neurocognitive characteristics and pharmacological treatment. Hell J Nucl Med. 2019;22(Suppl):123\u201332.","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"225_CR151","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0165-4608(00)00322-8","volume":"124","author":"SW Maluf","year":"2001","unstructured":"Maluf SW, Erdtmann B. Genomic instability in Down syndrome and Fanconi anemia assessed by micronucleus analysis and single-cell gel electrophoresis. Cancer Genet Cytogenet. 2001;124(1):71\u20135.","journal-title":"Cancer Genet Cytogenet"},{"issue":"13","key":"225_CR152","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/gb-2005-6-13-r107","volume":"6","author":"R Mao","year":"2005","unstructured":"Mao R, Wang X, Spitznagel EL Jr, Frelin LP, Ting JC, Ding H, et al. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart. Genome Biol. 2005;6(13):R107.","journal-title":"Genome Biol"},{"issue":"9","key":"225_CR153","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/ddy447","volume":"28","author":"D Marechal","year":"2019","unstructured":"Marechal D, Brault V, Leon A, Martin D, Lopes Pereira P, Loa\u00ebc N, et al. CBS overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a. Hum Mol Genet. 2019;28(9):1561\u201377.","journal-title":"Hum Mol Genet"},{"key":"225_CR154","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2020.00016","volume":"14","author":"C Mart\u00ednez-Cu\u00e9","year":"2020","unstructured":"Mart\u00ednez-Cu\u00e9 C, Rueda N. Cellular senescence in neurodegenerative diseases. Front Cell Neurosci. 2020;14:16.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"225_CR155","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000213592","volume":"40","author":"W Meier-Ruge","year":"1994","unstructured":"Meier-Ruge W, Bertoni-Freddari C, Iwangoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer\u2019s disease. Gerontology. 1994;40(5):246\u201352.","journal-title":"Gerontology"},{"key":"225_CR156","volume-title":"Biochemistry, Anaerobic Glycolysis","author":"EA Melkonian","year":"2019","unstructured":"Melkonian EA, Schury MP. Biochemistry, Anaerobic Glycolysis. Treasure Island: StatPearls Publishing; 2019."},{"issue":"Pt 2","key":"225_CR157","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2788.2004.00616.x","volume":"49","author":"CA Melville","year":"2005","unstructured":"Melville CA, Cooper SA, McGrother CW, Thorp CF, Collacott R. Obesity in adults with Down syndrome: a case-control study. J Intellect Disabil Res. 2005;49(Pt 2):125\u201333.","journal-title":"J Intellect Disabil Res"},{"issue":"5","key":"225_CR158","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jar.12449","volume":"31","author":"GV Mendonca","year":"2018","unstructured":"Mendonca GV, Borges A, Wee SO, Fernhall B. Oxygen uptake efficiency slope during exercise in adults with Down syndrome. J Appl Res Intellect Disabil. 2018;31(5):897\u2013904.","journal-title":"J Appl Res Intellect Disabil"},{"key":"225_CR159","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2147\/TCRM.S10235","volume":"6","author":"GV Mendonca","year":"2010","unstructured":"Mendonca GV, Pereira FD, Fernhall B. Reduced exercise capacity in persons with Down syndrome: cause, effect, and management. Ther Clin Risk Manag. 2010;6:601\u201310.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"225_CR160","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/gerona\/61.6.534","volume":"61","author":"EV Menshikova","year":"2006","unstructured":"Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, Goodpaster BH. Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci. 2006;61(6):534\u201340.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"225_CR161","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neubiorev.2016.09.012","volume":"71","author":"AF Mentis","year":"2016","unstructured":"Mentis AF. Epigenomic engineering for Down syndrome. Neurosci Biobehav Rev. 2016;71:323\u20137.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3580","key":"225_CR162","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.141.3580.535","volume":"141","author":"ET Mertz","year":"1963","unstructured":"Mertz ET, Fuller RW, Concon JM. Serum uric acid in young mongoloids. Science. 1963;141(3580):535.","journal-title":"Science"},{"issue":"6","key":"225_CR163","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.pediatrneurol.2007.08.003","volume":"37","author":"MV Miles","year":"2007","unstructured":"Miles MV, Patterson BJ, Chalfonte-Evans ML, Horn PS, Hickey FJ, Schapiro MB, et al. Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol. 2007;37(6):398\u2013403.","journal-title":"Pediatr Neurol"},{"issue":"11","key":"225_CR164","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0929-693X(97)88974-9","volume":"4","author":"C Mircher","year":"1997","unstructured":"Mircher C, Salabelle A, Peeters MA, Rabier D, Parvy P, Kamoun P, et al. Variation of amino acids in relation to age in Down syndrome subjects. Arch Pediatr. 1997;4(11):1093\u20139.","journal-title":"Arch Pediatr"},{"issue":"2","key":"225_CR165","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11248-013-9772-x","volume":"23","author":"K Miyamoto","year":"2014","unstructured":"Miyamoto K, Suzuki N, Sakai K, Asakawa S, Okazaki T, Kudoh J, et al. A novel mouse model for Down syndrome that harbor a single copy of human artificial chromosome (HAC) carrying a limited number of genes from human chromosome 21. Transgenic Res. 2014;23(2):317\u201329.","journal-title":"Transgenic Res"},{"issue":"2","key":"225_CR166","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.celrep.2018.06.033","volume":"24","author":"GO Mizuno","year":"2018","unstructured":"Mizuno GO, Wang Y, Shi G, Wang Y, Sun J, Papadopoulos S, et al. Aberrant calcium signaling in astrocytes inhibits neuronal excitability in a human Down syndrome stem cell model. Cell Rep. 2018;24(2):355\u201365.","journal-title":"Cell Rep"},{"key":"225_CR167","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fgene.2019.00606","volume":"10","author":"N Mollo","year":"2019","unstructured":"Mollo N, Nitti M, Zerillo L, Faicchia D, Micillo T, Accarino R, et al. Pioglitazone improves mitochondrial organization and bioenergetics in Down syndrome cells. Front Genet. 2019;10:606.","journal-title":"Front Genet"},{"key":"225_CR168","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1101\/sqb.2011.76.010868","volume":"76","author":"I Mor","year":"2011","unstructured":"Mor I, Cheung E, Vousden K. Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harbor Laboratory Press, Woodbury, NY. 2011;76:211\u20136.","journal-title":"Cold Spring Harbor Laboratory Press, Woodbury, NY"},{"key":"225_CR169","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.pbr.2019.08.001","volume":"251","author":"MDM Mu\u00f1iz Moreno","year":"2020","unstructured":"Mu\u00f1iz Moreno MDM, Brault V, Birling MC, Pavlovic G, Herault Y. Modeling Down syndrome in animals from the early stage to the 4.0 models and next. Prog Brain Res. 2020;251:91\u2013143.","journal-title":"Prog Brain Res."},{"issue":"1","key":"225_CR170","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0014-2999(91)90831-A","volume":"204","author":"H Nakanishi","year":"1991","unstructured":"Nakanishi H, Kamata O, Ukai K, Yamamoto K. Inhibitory effects of NMDA receptor antagonists on hypoxia-induced seizures in dietary Mg^+- deficient mice. Eur J Pharmacol. 1991;204(1):29\u201334.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"225_CR171","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2486\/indhealth.42.83","volume":"42","author":"B Nam","year":"2004","unstructured":"Nam B, Kim H, Choi Y, Lee H, Hong E-S, Park J-K, et al. Neurologic sequela of hydrogen sulfide poisoning. Ind Health. 2004;42(1):83\u20137.","journal-title":"Ind Health"},{"key":"225_CR172","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mrfmmm.2015.07.009","volume":"780","author":"D Necchi","year":"2015","unstructured":"Necchi D, Pinto A, Tillhon M, Dutto I, Serafini MM, Lanni C, et al. Defective DNA repair and increased chromatin binding of DNA repair factors in Down syndrome fibroblasts. Mutat Res. 2015;780:15\u201323.","journal-title":"Mutat Res"},{"key":"225_CR173","volume-title":"Principles of Biochemistry","author":"DL Nelson","year":"2008","unstructured":"Nelson DL, Cox MM, Lehninger AL. Principles of Biochemistry. New York: W.H Freeman; 2008."},{"issue":"254","key":"225_CR174","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/adc.47.254.672-a","volume":"47","author":"E Nelson","year":"1972","unstructured":"Nelson E, Benson PF. Elevated erythrocyte 2,3-diphosphoglycerate concentration in primary trisomic Down\u2019s syndrome. Arch Dis Child. 1972;47(254):672.","journal-title":"Arch Dis Child"},{"issue":"9","key":"225_CR175","doi-asserted-by":"publisher","first-page":"035634","DOI":"10.1242\/dmm.035634","volume":"11","author":"TL Nguyen","year":"2018","unstructured":"Nguyen TL, Duchon A, Manousopoulou A, Loa\u00ebc N, Villiers B, Pani G, et al. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A. Dis Model Mech. 2018;11(9):035634.","journal-title":"Dis Model Mech."},{"issue":"1\u20132","key":"225_CR176","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10863-014-9573-9","volume":"47","author":"DG Nicholls","year":"2015","unstructured":"Nicholls DG, Brand MD, Gerencser AA. Mitochondrial bioenergetics and neuronal survival modelled in primary neuronal culture and isolated nerve terminals. J Bioenerg Biomembr. 2015;47(1\u20132):63\u201374.","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"225_CR177","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1042\/BST20130070","volume":"41","author":"P Nicholls","year":"2013","unstructured":"Nicholls P, Marshall DC, Cooper CE, Wilson MT. Sulfide inhibition of and metabolism by cytochrome c oxidase. Biochem Soc Trans. 2013;41(5):1312\u20136.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"225_CR178","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/009841098158773","volume":"54","author":"RA Nicholson","year":"1998","unstructured":"Nicholson RA, Roth SH, Zhang A, Zheng J, Brookes J, Skrajny B, et al. Inhibition of respiratory and bioenergetic mechanisms by hydrogen sulfide in mammalian brain. J Toxicol Environ Health. 1998;54(6):491\u2013507.","journal-title":"J Toxicol Environ Health"},{"issue":"10","key":"225_CR179","doi-asserted-by":"publisher","first-page":"e7540","DOI":"10.1371\/journal.pone.0007540","volume":"4","author":"C Noll","year":"2009","unstructured":"Noll C, Planque C, Ripoll C, Guedj F, Diez A, Ducros V, et al. DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase. PLoS ONE. 2009;4(10):e7540.","journal-title":"PLoS ONE"},{"key":"225_CR180","first-page":"1","volume":"28","author":"NM Nura","year":"2008","unstructured":"Nura NM, Nuri MSh, Zienat Kh. Amino acids profile in mentally retarded Libyan children. Bull Egypt Soc Physiol Sci. 2008;28:1\u201310.","journal-title":"Bull Egypt Soc Physiol Sci"},{"issue":"5743","key":"225_CR181","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1126\/science.1114535","volume":"309","author":"A O'Doherty","year":"2005","unstructured":"O\u2019Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science. 2005;309(5743):2033\u20137.","journal-title":"Science"},{"issue":"10","key":"225_CR182","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/mnfr.201200162","volume":"56","author":"R Obeid","year":"2012","unstructured":"Obeid R, Hartmuth K, Herrmann W, Gortner L, Rohrer TR, Geisel J, et al. Blood biomarkers of methylation in Down syndrome and metabolic simulations using a mathematical model. Mol Nutr Food Res. 2012;56(10):1582\u20139.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"225_CR183","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41398-019-0578-3","volume":"9","author":"JS Orozco","year":"2019","unstructured":"Orozco JS, Hertz-Picciotto I, Abbeduto L, Slupsky CM. Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome. Transl Psychiatry. 2019;9(1):243.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"225_CR184","first-page":"18","volume":"22","author":"E Ozanturk","year":"2016","unstructured":"Ozanturk E, Ucar ZZ, Varol Y, Koca H, Demir AU, Kalenci D, et al. Urinary uric acid excretion as an indicator of severe hypoxia and mortality in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Rev Port Pneumol. 2016;22(1):18\u201326.","journal-title":"Rev Port Pneumol"},{"issue":"4","key":"225_CR185","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/biom10040653","volume":"10","author":"T Panagaki","year":"2020","unstructured":"Panagaki T, Randi EB, Szabo C. Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation and cellular bioenergetics in human Down syndrome fibroblasts. Biomolecules. 2020;10(4):653.","journal-title":"Biomolecules"},{"issue":"38","key":"225_CR186","doi-asserted-by":"publisher","first-page":"18769","DOI":"10.1073\/pnas.1911895116","volume":"116","author":"T Panagaki","year":"2019","unstructured":"Panagaki T, Randi EB, Augsburger F, Szabo C. Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome. Proc Natl Acad Sci USA. 2019;116(38):18769\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"225_CR187","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1210\/jcem-28-4-472","volume":"28","author":"SS Pant","year":"1968","unstructured":"Pant SS, Moser HW, Krane SM. Hyperuricemia in Down\u2019s syndrome. J Clin Endocrinol Metab. 1968;28(4):472\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"225_CR188","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ridd.2015.07.010","volume":"45\u201346","author":"EB Parisotto","year":"2015","unstructured":"Parisotto EB, Giaretta AG, Zamoner A, Moreira EAM, Fr\u00f6de TS, Pedrosa RC, et al. Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome. Res Dev Disabil. 2015;45\u201346:14\u201320.","journal-title":"Res Dev Disabil"},{"issue":"1 Pt 1","key":"225_CR189","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1006\/clim.2000.4834","volume":"95","author":"E Park","year":"2000","unstructured":"Park E, Alberti J, Mehta P, Dalton A, Sersen E, Schuller-Levis G. Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down\u2019s syndrome. Clin Immunol. 2000;95(1 Pt 1):62\u20139.","journal-title":"Clin Immunol"},{"issue":"4","key":"225_CR190","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/archpedi.154.4.408","volume":"154","author":"E Pastore","year":"2000","unstructured":"Pastore E, Marino B, Calzolari A, Digilio MC, Giannotti A, Turchetta A. Clinical and cardiorespiratory assessment in children with Down syndrome without congenital heart disease. Arch Pediatr Adolesc Med. 2000;154(4):408\u201310.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"47","key":"225_CR191","doi-asserted-by":"publisher","first-page":"28214","DOI":"10.1074\/jbc.M115.663179","volume":"290","author":"L Pecze","year":"2015","unstructured":"Pecze L, Blum W, Schwaller B. (2015) Routes of Ca2+ shuttling during Ca2+ oscillations focus on the role of mitochondrial Ca2+ handling and cytosolic Ca2+ buffers. J Biol Chem. 2015;290(47):28214\u201330.","journal-title":"J Biol Chem"},{"issue":"3","key":"225_CR192","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41419-019-1475-7","volume":"10","author":"M Peng","year":"2019","unstructured":"Peng M, Yang D, Hou Y, Liu S, Zhao M, Qin Y, et al. Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis. Cell Death Dis. 2019;10(3):228.","journal-title":"Cell Death Dis"},{"issue":"6 Pt 2","key":"225_CR193","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1016\/0272-0590(85)90124-1","volume":"5","author":"SA Persson","year":"1985","unstructured":"Persson SA, Cassel G, Sellstr\u00f6m A. Acute cyanide intoxication and central transmitter systems. Fundam Appl Toxicol. 1985;5(6 Pt 2):S150\u20139.","journal-title":"Fundam Appl Toxicol"},{"issue":"12","key":"225_CR194","doi-asserted-by":"publisher","first-page":"e84031","DOI":"10.1371\/journal.pone.0084031","volume":"8","author":"AC Phillips","year":"2013","unstructured":"Phillips AC, Sleigh A, McAllister CJ, Brage S, Carpenter TA, Kemp GJ, et al. Defective mitochondrial function in vivo in skeletal muscle in adults with Down\u2019s syndrome: a 31P-MRS study. PLoS ONE. 2013;8(12):e84031.","journal-title":"PLoS ONE"},{"issue":"6","key":"225_CR195","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/hmg\/dds529","volume":"22","author":"C Piccoli","year":"2013","unstructured":"Piccoli C, Izzo A, Scrima R, Bonfiglio F, Manco R, Negri R, et al. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects. Hum Mol Genet. 2013;22(6):1218\u201332.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"225_CR196","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1399-0004.1994.tb03985.x","volume":"45","author":"J Pincheira","year":"1994","unstructured":"Pincheira J, Rodriguez M, Bravo M, Navarrete MH, Lopez-Saez JF. Defective G2 repair in Down syndrome: effect of caffeine, adenosine and niacinamide in control and X-ray irradiated lymphocytes. Clin Genet. 1994;45(1):25\u201331.","journal-title":"Clin Genet"},{"issue":"5","key":"225_CR197","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41418-019-0442-2","volume":"27","author":"N Plotegher","year":"2020","unstructured":"Plotegher N, Perocheau D, Ferrazza R, Massaro G, Bhosale G, Zambon F, et al. Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload. Cell Death Differ. 2020;27(5):1588\u2013603.","journal-title":"Cell Death Differ"},{"issue":"1","key":"225_CR198","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1086\/321262","volume":"69","author":"M Pogribna","year":"2001","unstructured":"Pogribna M, Melnyk S, Pogribny I, Chango A, Yi P, James SJ. Homocysteine metabolism in children with Down syndrome: in vitro modulation. Am J Hum Genet. 2001;69(1):88\u201395.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"225_CR199","doi-asserted-by":"publisher","first-page":"25","DOI":"10.32614\/RJ-2011-004","volume":"3","author":"T Poisot","year":"2011","unstructured":"Poisot T. The digitize package: extracting numerical data from scatterplots. R J. 2011;3(1):25\u20136.","journal-title":"R J"},{"issue":"1","key":"225_CR200","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1038\/s41467-019-12739-9","volume":"10","author":"RK Powers","year":"2019","unstructured":"Powers RK, Culp-Hill R, Ludwig MP, Smith KP, Waugh KA, Minter R, et al. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Nat Commun. 2019;10(1):4766.","journal-title":"Nat Commun"},{"issue":"3","key":"225_CR201","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF02260938","volume":"8","author":"J Prince","year":"1994","unstructured":"Prince J, Jia S, B\u00e5ve U, Anneren G, Oreland L. Mitochondrial enzyme deficiencies in Down\u2019s syndrome. J Neural Transm Park Dis Dement Sect. 1994;8(3):171\u201381.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"3","key":"225_CR202","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0009-8981(82)90301-1","volume":"126","author":"R Puukka","year":"1982","unstructured":"Puukka R, Puukka M, Leppilampi M, Linna SL, Kouvalainen K. Erythrocyte adenosine deaminase, purine nucleoside phosphorylase and phosphoribosyltransferase activity in patients with Down\u2019s syndrome. Clin Chim Acta. 1982;126(3):275\u201381.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"225_CR203","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1352\/1944-7558-115.2.83","volume":"115","author":"M Rachidi","year":"2010","unstructured":"Rachidi M, Lopes C. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome. Am J Intellect Dev Disabil. 2010;115(2):83\u2013112.","journal-title":"Am J Intellect Dev Disabil"},{"key":"225_CR204","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ntt.2014.02.002","volume":"42","author":"BR Reed","year":"2014","unstructured":"Reed BR, Crane J, Garrett N, Woods DL, Bates MN. Chronic ambient hydrogen sulfide exposure and cognitive function. Neurotoxicol Teratol. 2014;42:68\u201376.","journal-title":"Neurotoxicol Teratol"},{"issue":"3","key":"225_CR205","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jpeds.2008.05.055","volume":"153","author":"T Reynolds","year":"2008","unstructured":"Reynolds T. Antioxidants do not improve early childhood development in children with Down\u2019s syndrome. J Pediatr. 2008;153(3):441.","journal-title":"J Pediatr"},{"key":"225_CR206","doi-asserted-by":"publisher","first-page":"509241","DOI":"10.1155\/2015\/509241","volume":"2015","author":"V Rodr\u00edguez-Sureda","year":"2015","unstructured":"Rodr\u00edguez-Sureda V, Vilches \u00c1, S\u00e1nchez O, Aud\u00ed L, Dom\u00ednguez C. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev. 2015;2015:509241.","journal-title":"Oxid Med Cell Longev"},{"issue":"25","key":"225_CR207","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM196512162732503","volume":"273","author":"F Rosner","year":"1965","unstructured":"Rosner F, Ong BH, Paine RS, Mahanand D. Biochemical differentiation of trisomic Down\u2019s syndrome (mongolism) from that due to translocation. N Engl J Med. 1965;273(25):1356\u201361.","journal-title":"N Engl J Med"},{"key":"225_CR208","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-7091-6721-2_4","volume":"67","author":"M Rosner","year":"2003","unstructured":"Rosner M, Kowalska A, Freilinger A, Prusa AR, Marton E, Hengstschl\u00e4ger M. Cell cycle and cell size regulation in Down syndrome cells. J Neural Transm Suppl. 2003;67:51\u20138.","journal-title":"J Neural Transm Suppl"},{"issue":"3","key":"225_CR209","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1352\/0047-6765(1998)036<0175:OPIPWD>2.0.CO;2","volume":"36","author":"SS Rubin","year":"1998","unstructured":"Rubin SS, Rimmer JH, Chicoine B, Braddock D, McGuire DE. Overweight prevalence in persons with Down syndrome. Ment Retard. 1998;36(3):175\u201381.","journal-title":"Ment Retard"},{"issue":"4","key":"225_CR210","doi-asserted-by":"publisher","first-page":"e0175437","DOI":"10.1371\/journal.pone.0175437","volume":"12","author":"A Saghazadeh","year":"2017","unstructured":"Saghazadeh A, Mahmoudi M, Ashkezari AD, Rezaie NO, Rezaei N. Systematic review and meta-analysis shows a specific micronutrient profile in people with Down Syndrome: lower blood calcium, selenium and zinc, higher red blood cell copper and zinc, and higher salivary calcium and sodium. PLoS ONE. 2017;12(4):e0175437.","journal-title":"PLoS ONE"},{"issue":"4","key":"225_CR211","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jnc.13932","volume":"140","author":"A Salminen","year":"2017","unstructured":"Salminen A, Kauppinen A, Kaarniranta K. Hypoxia\/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer\u2019s disease. J Neurochem. 2017;140(4):536\u201349.","journal-title":"J Neurochem"},{"issue":"22","key":"225_CR212","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1212\/WNL.0000000000002714","volume":"86","author":"M Sano","year":"2016","unstructured":"Sano M, Aisen PS, Andrews HF, Tsai W-Y, Lai F, Dalton AJ. Vitamin E in aging persons with Down syndrome: a randomized, placebo-controlled clinical trial. Neurology. 2016;86(22):2071\u20136.","journal-title":"Neurology"},{"issue":"2","key":"225_CR213","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","volume":"1410","author":"AH Schapira","year":"1999","unstructured":"Schapira AH. Mitochondrial involvement in Parkinson\u2019s disease, Huntington\u2019s disease, hereditary spastic paraplegia and Friedreich\u2019s ataxia. Biochim Biophys Acta. 1999;1410(2):159\u201370.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"225_CR214","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/occmed\/48.4.255","volume":"48","author":"JS Schneider","year":"1998","unstructured":"Schneider JS, Tobe EH, Mozley PD Jr, Barniskis L, Lidsky TI. Persistent cognitive and motor deficits following acute hydrogen sulphide poisoning. Occup Med (Lond). 1998;48(4):255\u201360.","journal-title":"Occup Med (Lond)"},{"issue":"11","key":"225_CR215","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/BF02233876","volume":"12","author":"LB Seeff","year":"1967","unstructured":"Seeff LB, Levitsky J, Tillman PW, Perou ML, Zimmerman HJ. Histopathology of the liver in Down\u2019s syndrome. Am J Dig Dis. 1967;12(11):1102\u201313.","journal-title":"Am J Dig Dis"},{"issue":"3","key":"225_CR216","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ridd.2013.12.008","volume":"35","author":"BB Seron","year":"2014","unstructured":"Seron BB, Greguol M. Assessment protocols of maximum oxygen consumption in young people with Down syndrome\u2013a review. Res Dev Disabil. 2014;35(3):676\u201385.","journal-title":"Res Dev Disabil"},{"issue":"6","key":"225_CR217","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ajhb.1117","volume":"13","author":"M Seven","year":"2001","unstructured":"Seven M, Cengiz M, T\u00fczgen S, \u0130scan MY. Plasma carnitine levels in children with Down syndrome. Am J Hum Biol. 2001;13(6):721\u20135.","journal-title":"Am J Hum Biol"},{"issue":"2","key":"225_CR218","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ajmg.1320140206","volume":"14","author":"BL Shapiro","year":"1983","unstructured":"Shapiro BL. Down syndrome\u2014a disruption of homeostasis. Am J Med Genet. 1983;14(2):241\u201369.","journal-title":"Am J Med Genet"},{"key":"225_CR219","first-page":"127","volume":"299","author":"VK Shukla","year":"1989","unstructured":"Shukla VK, Sethi AK, Garg SK, Ganguly NK, Kulkami SK. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils. Arch Int Pharmacodyn Ther. 1989;299:127\u201333.","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"2","key":"225_CR220","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1176\/ajp.111.2.139","volume":"111","author":"A Simon","year":"1954","unstructured":"Simon A, Ludwig C, Gofman JW, Crook GH. Metabolic studies in mongolism: serum protein-bound iodine, cholesterol, and lipoprotein. Am J Psychiatry. 1954;111(2):139\u201344.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"225_CR221","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/tera.1420240307","volume":"24","author":"JD Singh","year":"1981","unstructured":"Singh JD. The teratogenic effects of dietary Cassava on the pregnant albino rat: a preliminary report. Teratology. 1981;24(3):289\u201391.","journal-title":"Teratology"},{"issue":"11","key":"225_CR222","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1139\/y92-215","volume":"70","author":"B Skrajny","year":"1992","unstructured":"Skrajny B, Hannah RS, Roth SH. Low concentrations of hydrogen sulphide alter monoamine levels in the developing rat central nervous system. Can J Physiol Pharmacol. 1992;70(11):1515\u20138.","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"225_CR223","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1007\/s12035-019-1585-3","volume":"56","author":"M Sobol","year":"2019","unstructured":"Sobol M, Klar J, Laan L, Shahsavani M, Schuster J, Anner\u00e9n G, et al. Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with Down syndrome disclose dynamic dysregulations of key pathways and cellular functions. Mol Neurobiol. 2019;56(10):7113\u201327.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"225_CR224","first-page":"1059","volume":"26","author":"A Soler Mar\u00edn","year":"2011","unstructured":"Soler Mar\u00edn A, Xandri Graupera JM. Nutritional status of intellectual disabled persons with Down syndrome. Nutr Hosp. 2011;26(5):1059\u201366.","journal-title":"Nutr Hosp"},{"issue":"4","key":"225_CR225","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1074\/jbc.M114.594952","volume":"290","author":"WJ Song","year":"2015","unstructured":"Song WJ, Song EAC, Jung MS, Choi SH, Baik HH, Jin BK, et al. Phosphorylation and inactivation of glycogen synthase kinase 3\u03b2 (GSK3\u03b2) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). J Biol Chem. 2015;290(4):2321\u201333.","journal-title":"J Biol Chem."},{"issue":"9","key":"225_CR226","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ebiom.2015.07.038","volume":"2","author":"S Stern","year":"2015","unstructured":"Stern S, Segal M, Moses E. Involvement of potassium and cation channels in hippocampal abnormalities of embryonic Ts65Dn and Tc1 trisomic mice. EBioMedicine. 2015;2(9):1048\u201362.","journal-title":"EBioMedicine"},{"issue":"1","key":"225_CR227","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajmg.1320200116","volume":"20","author":"V Stocchi","year":"1985","unstructured":"Stocchi V, Magnani M, Cucchiarini L, Novelli G, Dallapiccola B. Red blood cell adenine nucleotides abnormalities in Down syndrome. Am J Med Genet. 1985;20(1):131\u20135.","journal-title":"Am J Med Genet"},{"issue":"1","key":"225_CR228","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/1567205012666150921100311","volume":"13","author":"BJ Strupp","year":"2016","unstructured":"Strupp BJ, Powers BE, Velazquez R, Ash JA, Kelley CM, Alldred MJ, et al. Maternal choline supplementation: A potential prenatal treatment for Down syndrome and Alzheimer\u2019s disease. Curr Alzheimer Res. 2016;13(1):97\u2013106.","journal-title":"Curr Alzheimer Res"},{"issue":"5 Pt 1","key":"225_CR229","first-page":"L581","volume":"269","author":"Y Su","year":"1995","unstructured":"Su Y, Block ER. Hypoxia inhibits l-arginine synthesis from l-citrulline in porcine pulmonary artery endothelial cells. Am J Physiol. 1995;269(5 Pt 1):L581\u20137.","journal-title":"Am J Physiol"},{"key":"225_CR230","doi-asserted-by":"publisher","first-page":"e16220","DOI":"10.7554\/eLife.16220","volume":"5","author":"KD Sullivan","year":"2016","unstructured":"Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. Trisomy 21 consistently activates the interferon response. Elife. 2016;5:e16220.","journal-title":"Elife"},{"issue":"15","key":"225_CR231","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1111\/febs.15214","volume":"287","author":"C Szabo","year":"2020","unstructured":"Szabo C. The re-emerging pathophysiological role of the cystathionine-\u03b2-synthase\u2014hydrogen sulfide system in Down syndrome. FEBS J. 2020;287(15):3150\u201360.","journal-title":"FEBS J"},{"issue":"4","key":"225_CR232","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/pr.117.014050","volume":"69","author":"C Szabo","year":"2017","unstructured":"Szabo C, Papapetropoulos A. International Union of Basic and Clinical Pharmacology. CII: Pharmacological modulation of H2S levels: H2S donors and H2S biosynthesis inhibitors. Pharmacol Rev. 2017;69(4):497\u2013564.","journal-title":"Pharmacol Rev."},{"issue":"Pt 2","key":"225_CR233","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-7793.1998.315bn.x","volume":"509","author":"MJ Taggart","year":"1998","unstructured":"Taggart MJ, Wray S. Hypoxia and smooth muscle function: key regulatory events during metabolic stress. J Physiol. 1998;509(Pt 2):315\u201325.","journal-title":"J Physiol"},{"issue":"2","key":"225_CR234","first-page":"354","volume":"14","author":"A Tamarkina","year":"1978","unstructured":"Tamarkina A, Filippov I, Annenkov G, Beniashvili G. Changes in the mole fraction ratio of lactate dehydrogenase subunits in the lymphocytes of Down\u2019s syndrome patients. Genetika. 1978;14(2):354\u20138.","journal-title":"Genetika"},{"issue":"7444","key":"225_CR235","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496(7444):238\u201342.","journal-title":"Nature"},{"issue":"1","key":"225_CR236","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008X(81)90109-5","volume":"58","author":"OO Tewe","year":"1981","unstructured":"Tewe OO, Maner JH. Long-term and carry-over effect of dietary inorganic cyanide (KCN) in the life cycle performance and metabolism of rats. Toxicol Appl Pharmacol. 1981;58(1):1\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"225_CR237","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/biof.184","volume":"37","author":"L Tiano","year":"2011","unstructured":"Tiano L, Busciglio J. Mitochondrial dysfunction and Down\u2019s syndrome: is there a role for coenzyme Q(10)? BioFactors. 2011;37(5):386\u201392.","journal-title":"BioFactors"},{"issue":"11","key":"225_CR238","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.neurobiolaging.2009.11.016","volume":"32","author":"L Tiano","year":"2011","unstructured":"Tiano L, Carnevali P, Padella L, Santoro L, Principi F, Brug\u00e8 F, et al. Effect of Coenzyme Q10 in mitigating oxidative DNA damage in Down syndrome patients, a double blind randomized controlled trial. Neurobiol Aging. 2011;32(11):2103\u20135.","journal-title":"Neurobiol Aging"},{"issue":"1\u20134","key":"225_CR239","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/biof.5520320119","volume":"32","author":"L Tiano","year":"2008","unstructured":"Tiano L, Padella L, Carnevali P, Gabrielli O, Bruge F, Principi F, et al. Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects. BioFactors. 2008;32(1\u20134):161\u20137.","journal-title":"BioFactors"},{"issue":"3","key":"225_CR240","doi-asserted-by":"publisher","first-page":"626.e1","DOI":"10.1016\/j.neurobiolaging.2011.03.025","volume":"33","author":"L Tiano","year":"2012","unstructured":"Tiano L, Padella L, Santoro L, Carnevali P, Principi F, Brug\u00e8 F, et al. Prolonged coenzyme Q10 treatment in Down syndrome patients, effect on DNA oxidation. Neurobiol Aging. 2012;33(3):626.e1-8.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"225_CR241","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/hmg\/ddr033","volume":"20","author":"S Trazzi","year":"2011","unstructured":"Trazzi S, Mitrugno VM, Valli E, Fuchs C, Rizzi S, Guidi S, et al. APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum Mol Genet. 2011;20(8):1560\u201373.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"225_CR242","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","volume":"1857","author":"L Tretter","year":"2016","unstructured":"Tretter L, Patocs A, Chinopoulos C. Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta. 2016;1857(8):1086\u2013101.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"225_CR243","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/nyas.13159","volume":"1378","author":"DD Tshala-Katumbay","year":"2016","unstructured":"Tshala-Katumbay DD, Ngombe NN, Okitundu D, David L, Westaway SK, Boivin MJ, et al. Cyanide and the human brain: perspectives from a model of food (cassava) poisoning. Ann NY Acad Sci. 2016;1378(1):50\u20137.","journal-title":"Ann NY Acad Sci"},{"issue":"7632","key":"225_CR244","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature20165","volume":"540","author":"PA Tyrakis","year":"2016","unstructured":"Tyrakis PA, Palazon A, Macias D, Lee KL, Phan AT, Velica P, et al. S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate. Nature. 2016;540(7632):236\u201341.","journal-title":"Nature"},{"key":"225_CR245","unstructured":"U.S. EPA. IRIS Toxicological Review of Hydrogen Cyanide and Cyanide Salts (Final Report). U.S. Environmental Protection Agency, Washington, DC. 2010;EPA\/635\/R-08\/016F."},{"issue":"1","key":"225_CR246","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cge.13586","volume":"97","author":"E Urbanus","year":"2020","unstructured":"Urbanus E, van Rijn S, Swaab HA. Review of neurocognitive functioning of children with sex chromosome trisomies: Identifying targets for early intervention. Clin Genet. 2020;97(1):156\u201367.","journal-title":"Clin Genet"},{"key":"225_CR247","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neubiorev.2019.01.001","volume":"98","author":"RA Vacca","year":"2019","unstructured":"Vacca RA, Bawari S, Valenti D, Tewari D, Nabavi SF, Shirooie S, et al. Down syndrome: neurobiological alterations and therapeutic targets. Neurosci Biobehav Rev. 2019;98:234\u201355.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"225_CR248","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bbadis.2012.12.011","volume":"1832","author":"D Valenti","year":"2013","unstructured":"Valenti D, De Rasmo D, Signorile A, Rossi L, de Bari L, Scala I, et al. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down\u2019s syndrome. Biochim Biophys Acta. 2013;1832(4):542\u201352.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"225_CR249","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/BJ20101908","volume":"435","author":"D Valenti","year":"2011","unstructured":"Valenti D, Manente GA, Moro L, Marra E, Vacca RA. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP\/PKA signalling pathway. Biochem J. 2011;435(3):679\u201388.","journal-title":"Biochem J"},{"issue":"2","key":"225_CR250","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/BJ20100581","volume":"431","author":"D Valenti","year":"2010","unstructured":"Valenti D, Tullo A, Caratozzolo MF, Merafina RS, Scartezzini P, Marra E, et al. Impairment of F1F0-ATPase, adenine nucleotide translocator and adenylate kinase causes mitochondrial energy deficit in human skin fibroblasts with chromosome 21 trisomy. Biochem J. 2010;431(2):299\u2013310.","journal-title":"Biochem J"},{"issue":"6265","key":"225_CR251","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.aac4854","volume":"350","author":"E Verdin","year":"2015","unstructured":"Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208\u201313.","journal-title":"Science"},{"issue":"8","key":"225_CR252","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jclinepi.2006.11.003","volume":"60","author":"SD Walter","year":"2007","unstructured":"Walter SD, Yao X. Effect sizes can be calculated for studies reporting ranges for outcome variables in systematic reviews. J Clin Epidemiol. 2007;60(8):849\u201352.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"225_CR253","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1667\/RR14407.1","volume":"185","author":"Y Wang","year":"2016","unstructured":"Wang Y, Chang J, Shao L, Feng W, Luo Y, Chow M, et al. Hematopoietic stem cells from Ts65Dn mice are deficient in the repair of DNA double-strand breaks. Radiat Res. 2016;185(6):630\u20137.","journal-title":"Radiat Res"},{"issue":"6","key":"225_CR254","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519\u201330.","journal-title":"J Gen Physiol"},{"issue":"Pt 2","key":"225_CR255","first-page":"159","volume":"33","author":"SE Watkins","year":"1989","unstructured":"Watkins SE, Thomas DE, Clifford M, Tidmarsh SF, Sweeney AE, Ah-Sing E, et al. Plasma amino acids in patients with senile dementia and in subjects with Down\u2019s syndrome at an age vulnerable to Alzheimer changes. J Ment Defic Res. 1989;33(Pt 2):159\u201366.","journal-title":"J Ment Defic Res"},{"issue":"24","key":"225_CR256","doi-asserted-by":"publisher","first-page":"9962","DOI":"10.1073\/pnas.1216575110","volume":"110","author":"JP Weick","year":"2013","unstructured":"Weick JP, Held DL, Bonadurer GF 3rd, Doers ME, Liu Y, Maguire C, et al. Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci USA. 2013;110(24):9962\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"225_CR257","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.bbabio.2012.02.033","volume":"1817","author":"B Westermann","year":"2012","unstructured":"Westermann B. Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta. 2012;1817(10):1833\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"225_CR258","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.brainresbull.2016.08.009","volume":"133","author":"HM Wilkins","year":"2017","unstructured":"Wilkins HM, Swerdlow RH. Amyloid precursor protein processing and bioenergetics. Brain Res Bull. 2017;133:71\u20139.","journal-title":"Brain Res Bull"},{"issue":"6","key":"225_CR259","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/diab.42.6.801","volume":"42","author":"JR Williamson","year":"1993","unstructured":"Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42(6):801\u201313.","journal-title":"Diabetes"},{"issue":"1","key":"225_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37(1):1\u201317.","journal-title":"Amino Acids"},{"issue":"4","key":"225_CR261","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.clnu.2019.05.028","volume":"39","author":"L Xicota","year":"2020","unstructured":"Xicota L, Rodr\u00edguez J, Langohr K, Fit\u00f3 M, Dierssen M, de la Torre R, et al. Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: implications for clinical management. Clin Nutr. 2020;39(4):1292\u2013300.","journal-title":"Clin Nutr"},{"issue":"5","key":"225_CR262","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1471-4159.1990.tb04948.x","volume":"55","author":"CM Yates","year":"1990","unstructured":"Yates CM, Butterworth J, Tennant MC, Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem. 1990;55(5):1624\u201330.","journal-title":"J Neurochem"},{"issue":"14","key":"225_CR263","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/hmg\/ddq179","volume":"19","author":"T Yu","year":"2010","unstructured":"Yu T, Li Z, Jia Z, Clapcote SJ, Liu C, Li S, et al. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet. 2010;19(14):2780\u201391.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"225_CR264","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jped.2016.04.012","volume":"93","author":"ME Zaki","year":"2017","unstructured":"Zaki ME, El-Bassyouni HT, Tosson A, Youness E, Hussein J. Coenzyme Q10 and pro- inflammatory markers in children with Down syndrome: clinical and biochemical aspects. J Pediatr (Rio J). 2017;93(1):100\u20134.","journal-title":"J Pediatr (Rio J)"},{"key":"225_CR265","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-61779-170-3_15","volume":"758","author":"SL Zeiger","year":"2011","unstructured":"Zeiger SL, Stankowski JN, McLaughlin B. Assessing neuronal bioenergetic status. Methods Mol Biol. 2011;758:215\u201335.","journal-title":"Methods Mol Biol"},{"issue":"1\u20132","key":"225_CR266","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cccn.2003.11.020","volume":"341","author":"I Zitnanov\u00e1","year":"2004","unstructured":"Zitnanov\u00e1 I, Koryt\u00e1r P, Aruoma OI, Sustrov\u00e1 M, Garaiov\u00e1 I, Muchov\u00e1 J, et al. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms? Clin Chim Acta. 2004;341(1\u20132):139\u201346.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"225_CR267","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/biom10050697","volume":"10","author":"K Zuhra","year":"2020","unstructured":"Zuhra K, Augsburger F, Majtan T, Szabo C. Cystathionine-\u03b2-synthase: molecular regulation and pharmacological inhibition. Biomolecules. 2020;10(5):697.","journal-title":"Biomolecules"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10020-020-00225-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00225-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T05:06:42Z","timestamp":1723871202000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-020-00225-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":267,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["225"],"URL":"https:\/\/doi.org\/10.1186\/s10020-020-00225-8","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"17 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}